Table 2.
Study | Year | Area | Design | Age of successful groups | No. of successful groups (male/female) | Age of failed groups | No. of failed groups (male/female) | Quality |
---|---|---|---|---|---|---|---|---|
Vitamin D | ||||||||
Yildirim et al. (57) | 2017 | Turkey | Cross-sectional | N/A | 170 (N/A) | N/A | 50 (N/A) | 7* |
Shahawy et al. (58) | 2018 | Egypt | Cross-sectional | 18–80 y | 105 (N/A) | 18–80 y | 45 N/A) | 7* |
Magsi et al. (2) | 2021 | Pakistan | Cross-sectional | 18–60 y | 88 (42/46) | 18–60 y | 36 (18/18) | 8* |
Shatla et al. (59) | 2021 | Saudi Arabia | Cross-sectional | N/A | 109 (N/A) | N/A | 42 (N/A) | 7* |
Shafrir et al. (56) | 2021 | Israel | Cross-sectional | N/A | 45821 (N/A) | N/A | 29722 (N/A) | 9* |
N/A, not available; y, years;
The “star system” of the Newcastle–Ottawa scale.